Form 4: Synopsys CFO Executes Pre-Planned Stock Transactions

Synopsys CFO Shelagh Glaser executed pre-planned transactions, exercising stock options and selling common stock, as detailed in a recent SEC Form 4 filing.

Summary

• Shelagh Glaser, CFO of Synopsys Inc. (SNPS), executed pre-planned transactions on September 5, 2025, under a Rule 10b5-1 trading plan adopted on January 13, 2025.
• Glaser exercised non-qualified stock options to acquire 2,612 shares of common stock at $348.17 per share and simultaneously sold 2,612 shares at $609.77 per share.
• She also exercised non-qualified stock options to acquire 1,043 shares of common stock at $354.45 per share and simultaneously sold 1,043 shares at $609.77 per share.
• Following these transactions, Glaser directly beneficially owns 15,317 shares of common stock.
• Remaining derivative holdings include 13,061 non-qualified stock options with an exercise price of $348.17 and an expiration date of December 2, 2029, and 6,409 non-qualified stock options with an exercise price of $354.45 and an expiration date of February 17, 2030.

Sentiment

Score: 7

Explanation: This is a routine insider transaction under a 10b5-1 plan, indicating planned activity rather than a reactive decision. The profitable exercise and sale are positive for the insider, and the retained holdings show continued alignment with shareholder interests.

Positives

• Execution of a Rule 10b5-1 plan demonstrates pre-planned, non-discretionary trading, which can mitigate concerns about opportunistic insider trading.
• The sale price of $609.77 per share is significantly higher than the exercise prices of $348.17 and $354.45, indicating a profitable transaction for the insider.
• The CFO retains a substantial number of common shares (15,317) and options (13,061 + 6,409), maintaining alignment with shareholder interests.

Negatives

• Insider selling, even under a 10b5-1 plan, can sometimes be perceived negatively by the market, as it reduces the insider's direct equity stake.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: May view the sale as a routine, pre-planned event, but some might interpret insider selling as a slight negative, despite the 10b5-1 plan. The retained holdings still align interests.
• Employees: No direct impact.
• Customers/Suppliers/Creditors: No direct impact.

Key Dates

Recommendation

The filing details routine, pre-scheduled insider transactions under a Rule 10b5-1 plan. While there is insider selling, it is not discretionary and the CFO retains a significant stake in the company. This type of filing typically does not warrant a change in investment recommendation unless it signals a broader, unexpected trend or a significant shift in insider holdings, which is not evident here. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on the company's fundamentals rather than this specific insider transaction.

Keywords

Synopsys, SNPS, Shelagh Glaser, CFO, Insider Trading, Form 4, Stock Option Exercise, 10b5-1 Plan, Share Sale, Beneficial Ownership